Svalbard – Talk Bio

Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR

4 weeks ago talkbio0Tagged Approved, choline, Hyperphagia, Prader-Willi Syndrome, Soleno, Svalbard, United States Food and Drug Administration, Vykat

FDA approval, Vykat XR, Prader-Willi syndrome, hyperphagia, Soleno Therapeutics, diazoxide choline

Abbott’s Spinal Cord Stimulation Systems Demonstrate Long-Term Efficacy in Chronic Pain Management

3 months ago talkbio0Tagged abbott, Approved, BurstDR, Chronic pain, Neurostimulation procedures of spinal cord tissue, non-surgical back pain, Stimulation procedure, Svalbard, United States Food and Drug Administration, XR

Abbott, spinal cord stimulation, chronic pain, BurstDR stimulation, Proclaim Plus, Proclaim XR, FDA approval, non-surgical back pain

FDA Approves Tris Pharma’s Onyda XR, First Liquid Non-Stimulant ADHD Medication for Pediatric Patients ###

11 months ago talkbio0Tagged Approved, Attention deficit hyperactivity disorder, clonidine, Extended Release Suspension, hydrochloride, Liquid medication, LiquiXR, Non-stimulant, Onyda, Pediatric brand name, Svalbard, Technology, Tris Pharma, United States Food and Drug Administration

Tris Pharma, Onyda XR, ADHD, Non-stimulant, Liquid medication, Pediatric patients, FDA approval, Clonidine hydrochloride, Extended-release oral suspension, LiquiXR technology